1.9, causing a minor overlap with control. Identification of heterozygote cells by immunoblot analysis, using anti-T2 antibody alone as a probe, was difficult, as previously reported. We therefore carried out immunoblot analysis, using as probes a mixture of anti-T2 antibody and the antibody against mitochondrial 3-ketoacyl-CoA thiolase (TI), another mitochondrial thiolase, and determined the ratio of the intensities of the T2 and T1 bands (T2/T1 ratio) using a densitometer. When the T2/T1 ratio was calculated, there was no overlap between the heterozygotes and normal controls. Hence, the heterozygotes can be unambiguously identified using this method. The thiolase activities and T2/T1 proteins in immunoblotting were detectable in peripheral lymphocytes, rectal mucosa, amniocytes, and liver. Thus, the postnatal diagnosis of 3-ketothiolase deficiency can be readily made using lymphocytes or rectal mucosa. The applicability of these methods in amniocytes indicates that prenatal diagnosis of this disease should be possible. 3KTD is an inherited metabolic disorder of isoleucine and ketone body catabolism (1-3), caused by a defect of T2 (4). It is an autosomal recessive disease. The clinical expression of 3KTD is highly variable. Typical manifestations are severe ketoacidosis and excessive excretion of 2-methyl-3-hydroxybutyrate, 2-methylacetoacetate, and tiglylglycine in urine. However, many patients with 3KTD have no symptoms other than the occurrence of episodic ketoacidosis in childhood (3) . On the other hand, some patients may develop chronic neurologic symptoms such as mental retardation, hypotonia, or gait disturbance as sequelae after severe ketoacidotic attacks ( 5 , 6). Early detection and treatment of this disorder are important, because patients with 3KTD may achieve normal development with early intervention. Hence, it will be useful to develop simple and reliable methods for camer detection and prenatal diagnosis.
In addition to T2, four other thiolases are currently known in mammals (7, 8) . These include T I , peroxisomal 3-ketoacyl-CoA thiolase, cytosolic acetoacetyl-CoA thiolase, and mitochondrial trifunctional protein. Of the five thiolases, all have acetoacetylCoA thiolase activity, except for the mitochondrial trifunctional protein (8) , although the specific activities do vary. However, only T2 possesses the peculiar property that its activity is enhanced by K+ ion when assayed with acetoacetyl-CoA as substrate (9) . Accordingly, acetoacetyl-CoA thiolase activity in tissues from patients with 3KTD is not activated by K+ ion (lo), whereas in normal controls the activity is increased to about double that in the absence of K+ ion.
We have extensively studied the molecular basis of 3KTD. In our previous study of 15 cases of 3KTD using cultured skin fibroblasts, no increase of the acetoacetyl-CoA thiolase activity in cells from all the patients by Kf ion was observed. When analyzed with immunoblot, T2 protein in cells from patients with 3KTD was undetectable or the intensity of the variant T2 band was extremely reduced (1 1 -13). However, T2 protein in 10 of 15 patients was efficiently labeled in a pulse-labeling experiment using [35S]methionine, suggesting T2 in these mutant cells was synthesized (13) . Thus, variant T2 appears to be unstable. In the recent sequence analysis, we have identified six mutations, 29 within the T2 gene of four cases, that are responsible for this 3KTD deficiency. Each of these different mutations, except one, produced a labile variant T2 protein that was undetectable with immunoblot analysis (1 4-18) .
Family studies have also been performed in some cases. In a thiolase assay of three families, the ratio of acetoacetyl-CoA thiolase activities in the presence and absence of K+ (+K/-K ratio) seemed to be rather low in obligatory carriers compared with that in normal controls (I 9, 20) . It was difficult to identify unequivocally heterozygotes when immunoblot analysis was performed using anti-T2 antibody alone (I 1). However, we observed that the identification of carriers could be convincingly achieved by performing immunoblot analysis using a mixture of anti-T2 and anti-T1 antibodies, with the T1 band serving as an internal standard (15, 16, 19, 20) .
We report here the identification of homozygotes and obligate heterozygotes of 3KTD deficiency in three unreported families as well as four previously examined families by using thiolase assay and immunoblot analysis of fibroblasts, and, in one family, lymphocytes and rectal mucosa, as well. Distribution of T2 in several other human tissues was also examined using these two methods. The results from this study confirm the usefulness of immunoblot analysis using the mixture of anti-T2 and anti-T1 antibodies as a probe for the identification of heterozygotes and for a prenatal diagnosis as well.
MATERIALS AND METHODS

Materials. Fibroblasts obtained from eight patients with 3KTD
(GKO 1, GK04, GK05, GK06, GK07, GKlO, GK12, and GK15) and the parents from the seven families and 15 normal controls were cultured in Eagle's minimum essential medium containing 10% FCS (vol/vol). Fibroblasts from 3KTD patients and their parents, obligate heterozygotes, were provided as follows: family I of GKOl were from Dr. N. Sakura, Hiroshima University, Japan (2 1); family 2 of GK04 and GK05, a son and father who are both affected, from Dr. R. B. H. Schutgens (19) ; and family 7 of GK15 from Dr. D. T. Whelan, McMaster University, Hamilton, Ontario, Canada. Peripheral lymphocytes were prepared from heparinized venous blood from GKOI, the father, and the mother, as well as six healthy volunteers, on a Ficoll-sodium metrizoate gradient (Nakarai Chemical Ltd., Tokyo, Japan). Amniocytes were obtained by amniocentesis performed at the 16th to 20th wk of gestation for a prenatal diagnosis of other diseases. Specimens of rectal mucosa were taken from GKO 1 and five controls: two specimens were biopsied for a diagnosis of other diseases, using Watson's intestinal biopsy capsule (Ferraris Development and Engineering Co. Ltd., London, UK), and three were taken at autopsy on patients with other diseases. Liver specimens were taken at autopsy from six individuals with other diseases, and all tissues were stored at -80°C until analysis.
Enzyme assay. Thiolase activities were measured with acetoacetyl-CoA and 3-ketooctanoyl-CoA as substrates, as described (4). The acetoacetyl-CoA thiolase activity was assayed in the presence and the absence of K+ ion, and the +K/-K ratio was calculated.
Immunoblot analysis. Antibodies against TI and T2 were prepared as described (7), and immunoblotting was performed by using a mixture of the two antibodies, anti-TI and anti-T2, as the first antibody, according to the method described elsewhere (4). The intensity of the bands was determined by densitometry, and the ratio of peak areas for T2 and TI bands (T2/T1 ratio) was calculated.
RESULTS
Thiolase activities in various normal human tissues. Table 1 summarizes thiolase activities, which were determined using acetoacetyl-CoA and 3-ketooctanoyl-CoA as substrates in several tissues, including fibroblasts, lymphocytes, rectal mucosa, amniocytes, and the liver. The specific activity of the thiolases in the normal controls was highest in the liver, followed by rectal mucosa, lymphocytes, fibroblasts, and amniocytes. The activities in fibroblasts and amniocytes appeared to be similar. The +K/ -K ratio was around 2.0 in all these tissues, although the specific activities did vary among tissues. These findings suggest that the ratio of T2 to total acetoacetyl-CoA thiolase activity present in cells is similar in all human tissues. The specific activity of 3-ketooctanoyl-CoA thiolase in each tissue appeared to be roughly proportional to that of acetoacetyl-CoA thiolase.
Thiolase activity in cells from index cases, obligate heterozygotes, and controls.
Values of the +K/-K ratio in fibroblasts from 15 normal controls ranged from 1.8 to 2.4 (mean value, 2.0), whereas the ratio was 1.0 in all eight 3KTD patients. The ratio in the parents ranged from 1.4 to 1.9 (mean, 1.6). The value in the obligate carriers was significantly lower than that in normal controls ( p < 0.0 I), but overlaps with controls were observed in three cases (+K/-K, 1.9 in one case; 1.8 in two cases).
Similarly, the +K/-K ratio in both lymphocytes and rectal mucosa from GKOl was also 1.0, and the +K/-K ratio in lymphocytes from the parents of GKO 1 was 1.5 and 1.3 as shown in Table 1 , suggesting that identification of heterozygotes by thiolase assay using lymphocytes as well as fibroblasts may be feasible.
Identification of heterozygotes using immunoblot analysis. GK04, GK05, the mother, and the brother of GK04 of family 2. Densitometric tracings of these blots are shown in Figure 1 B. No T2 band was detectable in either GK04 or GK05 (indicated as Pt and Fa, respectively in Fig. 1A) . A faint T2 band was detectable in the blot from the mother and the brother (lanes Mo and Br, respectively). In contrast, the T1 band was clearly detectable in all lanes. Peak b was undetectable for both GK04 and GK05. Although peak b is present in the blot from the mother and the brother, its intensity was much weaker than in controls.
Immunoblot analysis for T2 and T1 proteins were further carried out on the cultured fibroblasts from six additional families with 3KTD, followed by densitometry. We found that the T2/T1 ratio was zero in all eight index patients. Among their parents, T2 was detectable, but the T2/Tl ratio was markedly lower than in controls (Fig. 2) . No overlap of the T2/T1 ratio was observed between controls and obligate carriers of 3KTD.
Immunoblot detection of thiolases in various human tissues. Figure 3A shows immunoblots of T1 and T2 in amniocytes, lymphocytes, rectal mucosa, and human liver and fibroblasts from the normal controls. T1 and T2 bands were evident in all these specimens. In immunoblots of T l and T2 in lymphocytes, the intensity of the T i band was essentially the same in one patient (GKOI), his parents, and normal controls, whereas no T2 band and only a faint T2 band were detectable in cells from GKOl and in cells from his parents, respectively (Fig. 3B) . Figure  3C shows immunoblots of T1 and T2 in rectal mucosa from GKO 1 and normal controls. In the patient's specimen, a T 1 band was detected but a T2 band was not, whereas both bands were clearly visible in controls. and Ly,, lymphocytes from controls; RI and RZ, rectal mucosa from controls; Lvl and Lv2, liver from controls; F, fibroblasts from a control; Cl and C2, tissues from normal controls; P, GKOI; Fa and Mo, the father and mother of GKO 1, respectively; and E, purified human thiolases, T 1 and T2 (5 ng each of protein applied).
DISCUSSION
The enzymatic diagnosis of 3KTD is based on either the lack of increase in acetoacetyl-CoA thiolase activity with the addition of K+ ion (10) or the absence of thiolase activity when 2-methylacetoacetyl-CoA was used as substrate (2) . In this study, we have shown that the measurement of the K+/K-ratio of acetoacetyl-CoA thiolase activities in fibroblasts or lymphocytes appeared to be useful in identifying heterozygotes for 3KTD, but a small overlap of the values between normal controls and heterozygotes occurred. Middleton (23) previously determined T2 activity in eight cases of 3KTD obligate heterozygotes using 2-methylacetoacetyl-CoA as substrate. He reported that values in most of the heterozygotes were distinctly lower than in controls, but here, too, some overlaps between controls and heterozygotes occurred.
We have shown here that the immunoblot determination of the T2/Tl ratio is a more reliable method for the identification of homozygotes and heterozygotes of 3KTD. We previously experienced difficulty in identifying heterozygotes by immunoblot analysis using anti-T2 antibody alone (1 1). However, such ambiguity of the results was completely eliminated by the combined use of anti-TI antibody. The intensity of the T2 band can be assessed more accurately by comparing it with that of the T1 band. With this method, heterozygotes may be easily identified by only visual assessment of the immunoblots in many cases. It is possible that this method cannot be used for mutants that produce a stable variant T2 in an amount that is comparable to that of controls. However, such a case has not been found among 15 3KTD patients that we have examined so far (1 3). Hence, this method should be useful for most families with 3KTD. Because the number of families examined in this study is still small, it is important in the future to study the index cases in each family before attempting carrier detection or prenatal diagnosis. Immunoblotting requires a smaller number of cells and may provide more rapid and reliable results than enzyme assay (24) .
The finding that T2 is likely to be expressed in every human tissue may agree with the findings that the T2 gene has the features that are characteristic of housekeeping genes (25) . Peripheral lymphocytes or rectal mucosa are useful for the assay of the activity or the immunoblot analysis of the thiolases. The specific activities in these tissues are higher than in fibroblasts. Unlike cultured skin fibroblasts, the results may be readily obtainable using these tissues. In a preliminary experiment, we also detected T2 protein in chorionic villi from a normal individual (data not shown). Thus, these findings suggest that it is possible to perform prenatal diagnosis of this disease using amniocytes or chorionic villi.
